Searchable abstracts of presentations at key conferences in endocrinology

ea0078p62 | Thyroid | BSPED2021

Hypothyroid screening in children with down syndrome - a service evaluation

Harley Rachael , Smith Sarah , Hamza Sherin , Guftar Shaikh M.

Background: Individuals with Down Syndrome are at increased risk of developing thyroid disease. Given thyroid disorders represent a preventable cause of neurodevelopmental impairment, early detection and treatment are essential to maximise cognitive abilities in this already impaired population. This service evaluation sought to assess the efficacy of the Down Syndrome Hypothyroid Screening programme in its uptake and subsequent diagnosis of hypothyroidism.<p class="abstex...

ea0039ep120 | Thyroid | BSPED2015

Combined hypothyroidism and hypoparathyroidism in an infant following maternal administration of Iodine131 in early pregnancy

Sinka Sarita , Jones Jeremy , Staines Jonathan , Kinmond Sheena , Donaldson Malcom , Guftar Shaikh M

Background: In adults, hypoparathyroidism is a rare, but recognised complication of radioactive Iodine therapy. Hypothyroidism has been reported in neonates who have been exposed to Iodine131 in-utero, however, only one case of neonatal hypoparathyroidism secondary to maternal Iodine131 therapy has been described in the literature. To our knowledge this is the first case in the UK.Case presentation: A 27-year-old woman received two ...

ea0036P18 | (1) | BSPED2014

Suppression of bone turnover and its determinants in children receiving bisphosphonate therapy

Kyriakou Andreas , McNeilly Jane D , McMillan Martin , Guftar Shaikh M , Mason Avril , Faisal Ahmed S

Introduction: Bisphosphonate therapy (BPT) reduces osteoclast activity and may be associated with adynamic bone turnover. The extent of suppression of bone turnover and its determinants are unclear.Methods: Markers of bone metabolism were evaluated in 15 children (9M/6F) receiving cyclical BPT intravenously for osteoporosis. The median age at first biochemical assessment was 10.8 years (0.16, 16.3). Serum type I collagen cross-linked C-telopeptide (CTX),...